Lirimilast

DB20727ExperimentalSmall molecule

Lirimilast is a small molecule drug. The usage of the INN stem '-milast' in the name indicates that Lirimilast is a Phosphodiesterase-4 (PDE4) inhibitor. Lirimilast has a monoisotopic molecular weight...

Formula / weight: C₁₇H₁₂Cl₂N₂O₆S · 443.25 g/mol (avg)

Resolves to

Compound

UNIIGDK3KY5FCUCAS329306-27-6ChEMBLCHEMBL1922282ChEBI750290PubChem6433118

Structure

InChIKeyYPFLFUJKZDAXRA-UHFFFAOYSA-NSMILESCS(=O)(=O)OC1=CC=C2C(OC(C(=O)C3=C(Cl)C=C(Cl)C=C3)=C2NC(N)=O)=C1

Targets

Q07343PDE4BQ08499PDE4DP27815PDE4A

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lirimilast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account